Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cerebrospinal fluid levels of triamcinolone acetonide after intratympanic application
2019-001863-60Phase 2Completed
- Sponsor
- Medical University of Vienna
- Start
- Jul 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of triamcinolone acetonide in inner ear disorder, sponsored by Medical University of Vienna. Primary endpoint: Levels of triamcinolone acetonide in cerebrospinal fluid. Started Jul 2019; status: completed.
02
Drugs
triamcinolone acetonide
03
Conditions
inner ear disorder
Beyond the preview
Go deeper on 2019-001863-60.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001863-60.